CG Share Price

CG Share Price

NASDAQ: CGON | Mid Cap | Healthcare
$80.03
+$0.98 (1.24%) Last updated on 19 Nov, 2026 | 01:27 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

CG Stock Performance

Open
$79.13
Prev. Close
$79.05
Circuit Range
N/A
Day Range
$77.44 - $82.01
Year Range
$37.10 - $91.94
Volume
89,427
Average Traded
$79.89

CG Share Price Today

As of 19 November 2026, CG Oncology, Inc.'s share price is $80.03. The stock opened at $79.13, compared to its previous close of $79.05. During today's trading session, CG Oncology, Inc.'s share price traded between $77.44 and $82.01, with an average price of $79.73. Over the past 52 weeks, the stock has recorded a high of $91.94 and a low of $37.10. In terms of performance, CG Oncology, Inc.'s share price has risen by 28.55% over the last six months and is up 78.70% on a year-on-year basis.

CG Share Price Chart

Line chart of the CG price trend over the selected period. The price rose overall, ranging from 77.44 to 81.96, ending at 80.03.
$77.44$82.01
L
Show Current Price
H

CG Stock Fundamentals & Key Indicators

Market Cap
$6.19B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.66
Revenue (TTM)
$4.04B
Return On Equity (TTM)
-23.96%
Profit Margin
-3985.15%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-37.71%

CG Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$2.32$1.08$1.16$1.60
Net Profit-$41.31-$60.20-$79.06-$56.89
Net Profit Margin-1780.60%-5574.07%-6815.52%-3555.63%
Income ChangeN/A-45.73%-31.33%28.04%

CG Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$1.14$4.04
Net Profit-$88.04-$161.00
Net Profit Margin-7722.81%-3985.15%
Income ChangeN/A-82.87%

CG Balance Sheet

All figures in USD Million

Particulars20252024
Non Current Assets32.120.59
Current Assets759.48754.21
Total Assets791.59754.8
Non Current Liabilities8.150.05
Current Liabilities30.8421.37
Total Liabilities38.9921.42
Shareholders' Equity752.6733.38

CG Cash Flow

Annually

All figures in USD Million

Particulars20252024
Operating-132.35-78.71
Investing-245.82-300.76
Financing153.59628.28

About CG

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing its product candidate, cretostimogene grenadenorepvec, for patients with bladder cancer. The company's candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.

CG Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$63.65
$80.08
+23.94%
Oct 2026
$70.67
$64.61
-8.99%
Sep 2026
$75.53
$70.99
-10.16%
Aug 2026
$71.04
$79.02
+11.02%
Jul 2026
$70.70
$71.17
+0.28%
Jun 2026
$61.27
$70.97
+14.01%
May 2026
$67.63
$62.26
-6.80%
Apr 2026
$68.22
$66.80
-1.46%
Mar 2026
$57.69
$67.79
+15.41%
Feb 2026
$51.97
$58.74
+12.99%
Jan 2026
$41.41
$51.98
+25.14%
Dec 2025
$45.11
$41.54
-7.25%

CG Share Price FAQs